Doping with testosterone and androgenic/anabolic steroids: Impact on health, screening tools and medical care
Author:
- 28 March 2023
- journal article
- conference paper
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 84 (3) , 401-405
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Insulin-like Peptide 3 (INSL3) in Men With Congenital Hypogonadotropic Hypogonadism/Kallmann Syndrome and Effects of Different Modalities of Hormonal Treatment: A Single-Center Study of 281 PatientsThe Journal of Clinical Endocrinology & Metabolism, 2014
- Determination of Raloxifene in Urine by Liquid Chromatography–Tandem Mass Spectrometry for DopingJournal of Analytical Toxicology, 2013
- Women and Anabolic Steroids: An Analysis of a Dozen UsersClinical Journal of Sport Medicine, 2010
- Confiscated black market products and nutritional supplements with non‐approved ingredients analyzed in the cologne doping control laboratory 2009Drug Testing and Analysis, 2010
- Analysis of anabolic steroids in human hair using LC–MS/MSSteroids, 2010
- Endogenous Steroid Profiling in the Athlete Biological PassportEndocrinology and Metabolism Clinics of North America, 2010
- The Rationale for Banning Human Chorionic Gonadotropin and Estrogen Blockers in SportThe Journal of Clinical Endocrinology & Metabolism, 2006
- Effects of Human Recombinant Luteinizing Hormone and Follicle-Stimulating Hormone in Patients with Acquired Hypogonadotropic Hypogonadism: Study of Sertoli and Leydig Cell Secretions and InteractionsThe Journal of Clinical Endocrinology & Metabolism, 2000
- Psychiatric and Medical Effects of Anabolic-Androgenic Steroid Use in WomenPsychotherapy and Psychosomatics, 1999
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996